Cargando…

SAT372 Obstructive Sleep Apnea (OSA) Risk Among Patients With Polycystic Ovary Syndrome (PCOS)

Disclosure: J.P. Christ: None. K. Shinkai: None. J. Corley: None. L. Pasch: None. M.I. Cedars: None. H. Huddleston: None. Background: Risk of OSA is increased up to seven-fold among patients with PCOS independent of body mass index (BMI). The cause of this increased risk is poorly understood. Likely...

Descripción completa

Detalles Bibliográficos
Autores principales:	Christ, Jacob P, Shinkai, Kanade, Corley, Jamie, Pasch, Lauri, Cedars, Marcelle Ivonne, Huddleston, Heather
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555059/ http://dx.doi.org/10.1210/jendso/bvad114.1677

Ejemplares similares

SAT353 Relevance of Ovarian Morphology Among Adolescents With Polycystic Ovary Syndrome (PCOS)
por: Christ, Jacob P, et al.
Publicado: (2023)

OR15-5 Cognitive Function in Reproductive Aged Individuals with Polycystic Ovary Syndrome
por: Cedars, Marcelle, et al.
Publicado: (2022)

Ovarian morphology is associated with insulin resistance in women with polycystic ovary syndrome: a cross sectional study
por: Reid, Sara Pittenger, et al.
Publicado: (2017)

SAT388 Does Obesity Drive the Development of Polycystic Ovary Syndrome (PCOS)? An Epidemiologic Study
por: Amiri, Mina, et al.
Publicado: (2023)

SAT365 Prevalence of Polycystic Ovary Syndrome (PCOS) in Health System and Insurer Records vs. the Prevalence in the Population: Evidence for the Significant Underdiagnosis and Undertreatment of PCOS
por: Hatoum, Sana, et al.
Publicado: (2023)

Endophenotypic correlates of cognitive function in reproductive-age individuals with polycystic ovary syndrome
por: Huddleston, Heather G., et al.
Publicado: (2022)

SAT363 The Prevalence And Phenotype Of Polycystic Ovary Syndrome (PCOS) In A Community-Based Population In Sub-Sahara Africa: The Nigeria-PEP Study
por: Makwe, Christian Chigozie, et al.
Publicado: (2023)

SAT350 PCOS and the Diagnostic Experience: Results From a Diverse United States Cohort Study
por: Huddleston, Heather, et al.
Publicado: (2023)

MON-231 Dietary Interventions Can Ameliorate Polycystic Ovary Syndrome (PCOS) Traits in a PCOS Mouse Model
por: Rodriguez Paris, Valentina, et al.
Publicado: (2019)

SAT-224 Polycystic Ovary Syndrome with Adrenal Hyperandrogenemia and Refractory Hirsutism
por: Parveen, Sanober, et al.
Publicado: (2019)

OR33-1 Metabolic Inflexibility in Obese versus Lean Women with Polycystic Ovary Syndrome (PCOS): Is PCOS Status or Adiposity the Critical Factor?
por: Gebara, Nour, et al.
Publicado: (2019)

SUN-012 Role of Leptin-Receptor Expressing Cells in the Pathogenesis of Polycystic Ovary Syndrome (PCOS)
por: Cara, Alexandra, et al.
Publicado: (2020)

SAT-024 Investigating Racial and Ethnic Comorbidity Patterns of Polycystic Ovary Syndrome
por: Actkins, Ky’Era, et al.
Publicado: (2020)

SAT370 Economic Burden of Endometrial Cancer Associated with Polycystic Ovary Syndrome
por: Pace, Lauren Arielle, et al.
Publicado: (2023)

Current Guidelines for Diagnosing PCOS
por: Christ, Jacob P., et al.
Publicado: (2023)

SAT386 Constitutive Overexpression Of Microrna-93 As A Cause Of Metabolic Dysfunction And Hyperandrogenism In Polycystic Ovary Syndrome (PCOS): Evidence From A Transgenic (Mir-93+) Murine Model
por: Chen, Yen-Hao, et al.
Publicado: (2023)

FRI458 Rare Pathogenic Missense Variants in LMNA Identified in Women with Polycystic Ovary Syndrome (PCOS)
por: Bauer, Rosemary, et al.
Publicado: (2023)

PMON245 Clinical Phenotypes of Polycystic Ovary Syndrome (PCOS) in Nigerian Women: Preliminary Results of the Nigeria PCOS Epidemiology & Phenotype (Nigeria-Pep) Study
por: Balogun, Mobolanle, et al.
Publicado: (2022)

SAT-017 Relationship Between Vitamin D Levels and Signs of Polycystic Ovary Syndrome
por: Smykalova, Anastasia, et al.
Publicado: (2020)

SAT381 Effect of Obesity on Androgen-induced Splenic Dysregulation in Polycystic Ovary Syndrome
por: Rezq, Samar, et al.
Publicado: (2023)

MON-234 Targeted Profiling of Plasma MicroRNAs in Women with Polycystic Ovary Syndrome (PCOS): Impact of Obesity
por: Almawi, Wassim, et al.
Publicado: (2019)

MON-213 Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Factors in Reproductive-Age Women with Polycystic Ovary Syndrome (PCOS) Using the 2014 Androgen Excess and PCOS Society Criteria for the Polycystic Ovarian Morphology
por: Kazemi, Maryam, et al.
Publicado: (2019)

Polycystic ovary syndrome is associated with nonalcoholic steatohepatitis in women of reproductive age
por: Maldonado, Stephanie S., et al.
Publicado: (2022)

SUN-013 Cardiometabolic Profile of Brazilian Women with Polycystic Ovary Syndrome (PCOS): A Systematic Review and Meta-Analysis
por: Marchesan, Lucas Bandeira, et al.
Publicado: (2020)

MON-LB010 Cyclic Progesterone Therapy for Androgenic Polycystic Ovary Syndrome (PCOS) - A Systematic Review of the Literature
por: Shirin, Sonia, et al.
Publicado: (2020)

Lifestyle, Anxiety,Depression, and Clinical Profile in Women With Polycystic Ovary Syndrome: Initial Results From the Brazilian PCOS Study
por: Spritzer, Poli Mara, et al.
Publicado: (2021)

SAT-018 Androgen Actions in Adipose Tissue and the Brain Are Key Mediators in the Development of Polycystic Ovary Syndrome
por: Cox, Madeleine J, et al.
Publicado: (2020)

SAT-015 Incidence and Predictors of Hypertension in a Cohort of Australian Women with and Without Polycystic Ovary Syndrome
por: Kakoly, Nadira Sultana, et al.
Publicado: (2020)

SAT356 Predicting Nonalcoholic Fatty Liver Disease in Adolescent Girls with Polycystic Ovary Syndrome and Obesity
por: Lo, Jaclyn S, et al.
Publicado: (2023)

SAT357 Rising Incidence, Health Resource Utilization and Costs of Polycystic Ovary Syndrome in the United Kingdom
por: Berni, Tom, et al.
Publicado: (2023)

SAT-023 Osteosarcopenia in Reproductive-Aged Women with Polycystic Ovary Syndrome: A Multicenter Case-Control Study
por: Kazemi, Maryam, et al.
Publicado: (2020)

SAT485 Knockout Of TLR4 Alters Reproductive And Metabolic Outcomes In Mouse Model Of Polycystic Ovary Syndrome
por: Dominique Wiggins, Kiara, et al.
Publicado: (2023)

OR08-2 Androgen Receptor- Vs Estrogen Receptor-Mediated Actions in the Development of Distinct Clinical Polycystic Ovary Syndrome (PCOS) Phenotypes
por: Aflatounian, Ali, et al.
Publicado: (2019)

MON-029 Polycystic Ovary Syndrome (PCOS) in Adolescent Girls:Toward a Simple On-Treatment Predictor of Post-Treatment Ovulation Rate
por: Ibanez, Lourdes, et al.
Publicado: (2020)

MON-LB9 Cyclic Progesterone Therapy in Androgenic Polycystic Ovary Syndrome (PCOS) - Person-Related 6-Month Experience Changes
por: Shirin, Sonia, et al.
Publicado: (2020)

ODP642 Differences in hormonal profiles and vitamin D status depending on the insulin sensitivity status in women with polycystic ovary syndrome (PCOS).
por: Ozga-Piszczek, Katarzyna, et al.
Publicado: (2022)

SAT366 Expression of Amyloid-related Proteins Associated With Dementia in Polycystic Ovary Syndrome Compared to a Control Population
por: Butler, Alexandra E, et al.
Publicado: (2023)

SAT390 Western Diet Exacerbates Colonic Mitochondrial Dysfunction in the Hyperandrogenemic Female Rat Model of Polycystic Ovary Syndrome
por: Edwards, Kristin, et al.
Publicado: (2023)

SAT-004 Prevalence of Abnormalities of Glucose Metabolism in Teenage Indian Girls with PCOS
por: Talwar, Vipan
Publicado: (2020)

SAT379 Potassium Levels in Women with PCOS Using Spironolactone for Long-term
por: Oliveira, Thais Areias, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cv7vis3qbca1310qphv0e9b5ar